Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 Oct;197(10):943-945.
doi: 10.1007/s00066-021-01824-y. Epub 2021 Jul 23.

[Virtual prostatectomy using single dose radiotherapy]

[Article in German]
Mohamed Shelan  1 , Elena Riggenbach  2 , Daniel M Aebersold  2
Affiliations
Comment

[Virtual prostatectomy using single dose radiotherapy]

[Article in German]
Mohamed Shelan et al. Strahlenther Onkol. 2021 Oct.
No abstract available

PubMed Disclaimer

Comment on

References

Literatur

    1. Brand DH, Tree AC, Ostler P et al (2019) Intensity-modulated fractionated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): acute toxicity findings from an international, randomised, open-label, phase 3, non-inferiority trial. Lancet Oncol 20(11):1531–1543. https://doi.org/10.1016/S1470-2045(19)30569-8 - DOI - PubMed - PMC
    1. Zilli T, Franzese C, Bottero M et al (2019) Single fraction urethra-sparing prostate cancer SBRT: phase I results of the ONE SHOT trial. Radiother Oncol 139:83–86. https://doi.org/10.1016/j.radonc.2019.07.018 - DOI - PubMed
    1. Morton G, Mcguffin M, Chung HT et al (2020) Prostate high dose-rate brachytherapy as monotherapy for low and intermediate risk prostate cancer: efficacy results from a randomized phase II clinical trial of one fraction of 19 Gy or two fractions of 13.5 Gy. Radiother Oncol 146:90–96. https://doi.org/10.1016/j.radonc.2020.02.009 - DOI - PubMed
    1. Gomez-iturriaga A, Buchser D, Mayrata E et al (2020) Pattern of relapse and dosimetric analysis of a single dose 19 Gy HDR-brachytherapy phase II trial. Radiother Oncol 146:16–20. https://doi.org/10.1016/j.radonc.2020.01.025 - DOI - PubMed
    1. Dearnaley D, Syndikus I, Mossop H et al (2016) Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5‑year outcomes of the randomised, non-inferiority, phase 3 CHHiP trial. Lancet Oncol 17(8):1047–1060. https://doi.org/10.1016/S1470-2045(16)30102-4 - DOI - PubMed - PMC

LinkOut - more resources